rs104895081

Variant summary

Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3PP5

The NM_000243.3(MEFV):​c.800C>T​(p.Thr267Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000118 in 1,614,258 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00012 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00012 ( 0 hom. )

Consequence

MEFV
NM_000243.3 missense

Scores

1
1
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:6U:8O:2

Conservation

PhyloP100: -1.98
Variant links:
Genes affected
MEFV (HGNC:6998): (MEFV innate immunity regulator, pyrin) This gene encodes a protein, also known as pyrin or marenostrin, that is an important modulator of innate immunity. Mutations in this gene are associated with Mediterranean fever, a hereditary periodic fever syndrome. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 4 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.832
PP5
Variant 16-3254268-G-A is Pathogenic according to our data. Variant chr16-3254268-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 2544.We mark this variant Likely_pathogenic, oryginal submissions are: {Likely_pathogenic=2, not_provided=2, Uncertain_significance=6, Pathogenic=1}. Variant chr16-3254268-G-A is described in Lovd as [Likely_pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
MEFVNM_000243.3 linkuse as main transcriptc.800C>T p.Thr267Ile missense_variant 2/10 ENST00000219596.6 NP_000234.1
MEFVNM_001198536.2 linkuse as main transcriptc.277+2043C>T intron_variant NP_001185465.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
MEFVENST00000219596.6 linkuse as main transcriptc.800C>T p.Thr267Ile missense_variant 2/101 NM_000243.3 ENSP00000219596 P3O15553-2

Frequencies

GnomAD3 genomes
AF:
0.000125
AC:
19
AN:
152246
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000723
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000206
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000159
AC:
40
AN:
251456
Hom.:
0
AF XY:
0.000184
AC XY:
25
AN XY:
135908
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000202
Gnomad ASJ exome
AF:
0.0000992
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000327
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000185
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.000118
AC:
172
AN:
1461894
Hom.:
0
Cov.:
32
AF XY:
0.000131
AC XY:
95
AN XY:
727248
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.000157
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000325
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000112
Gnomad4 OTH exome
AF:
0.000199
GnomAD4 genome
AF:
0.000125
AC:
19
AN:
152364
Hom.:
0
Cov.:
32
AF XY:
0.000121
AC XY:
9
AN XY:
74510
show subpopulations
Gnomad4 AFR
AF:
0.0000721
Gnomad4 AMR
AF:
0.0000653
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000207
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000206
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000162
Hom.:
0
Bravo
AF:
0.000110
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.000140
AC:
17
EpiCase
AF:
0.0000545
EpiControl
AF:
0.000237

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:6Uncertain:8Other:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Familial Mediterranean fever Pathogenic:2Uncertain:3Other:1
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpOct 17, 2022This sequence change replaces threonine, which is neutral and polar, with isoleucine, which is neutral and non-polar, at codon 267 of the MEFV protein (p.Thr267Ile). This variant is present in population databases (rs104895081, gnomAD 0.03%). This missense change has been observed in individual(s) with familial Mediterranean fever and/or juvenile idiopathic arthritis or other autoinflammatory conditions (PMID: 9668175, 10737992, 16378925, 17489852, 20485448, 21413889, 23505238, 23588594, 24469716, 26003477). ClinVar contains an entry for this variant (Variation ID: 2544). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The isoleucine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on MEFV function (PMID: 33733382). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Uncertain significance, criteria provided, single submitterclinical testingMendelicsMay 28, 2019- -
not provided, no classification providedliterature onlyUnité médicale des maladies autoinflammatoires, CHRU Montpellier-- -
Likely pathogenic, criteria provided, single submittercurationLaboratory of Medical Genetics, National & Kapodistrian University of AthensFeb 01, 2024- -
Pathogenic, no assertion criteria providedliterature onlyOMIMAug 01, 1998- -
Uncertain significance, no assertion criteria providedclinical testingCounsylMay 14, 2018- -
not provided Pathogenic:2Uncertain:2
Uncertain significance, criteria provided, single submitterclinical testingGeneDxSep 25, 2023Observed with a pathogenic variant on the same allele (in cis) in an individual with familial Mediterranean fever in published literature (Oztuzcu et al., 2014); In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 23505238, 20485448, 10737992, 25703702, 29178647, 28631068, 29314707, 29599418, 23588594, 16378925, 17384215, 11175300, 9668175, 26247045, 22975760, 29260407, 27457448, 28386255, 28624931, 27051312, 29735907, 29200027, 30488432, 20721559, 20645115, 15951859, 26003477, 34426522, 33733382, 36223753, 17489852, 24469716, 11781702) -
Uncertain significance, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenNov 01, 2020- -
Likely pathogenic, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Likely pathogenic, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
not specified Pathogenic:1Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpJan 12, 2024Variant summary: MEFV c.800C>T (p.Thr267Ile) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00016 in 251456 control chromosomes (gnomAD). This frequency is not significantly higher than expected for a pathogenic variant in MEFV causing Familial Mediterranean Fever, allowing no conclusion about variant significance. c.800C>T has been reported in the literature in homozygous, compound heterozygous, complex compound heterozygous and heterozygous genotypes, in studies of multiple individuals affected with and/or meeting established clinical criteria of Familial Mediterranean Fever (e.g. Bernot_1998, Ceylan_2012, Cornelius_2010, Dogan_2015, Giaglis_2007, Medlej-Hashim_2000, Moradian_2010). The extent of genotyping reported was variable ranging from targeted analysis to full sequencing of the MEFV gene. At-least one of these reports included a patient in whom two other bonafide pathogenic variants that are well reported as causative of FMF, namely p.Met694Val and p.Val726Ala were identified (Cornelius_2010). In 2012, a group of clinical and molecular experts reached a consensus to test for a total of 14 MEFV variants, including p.Thr267Ile which they described as clearly pathogenic (Shinar_2012). In 2018, the experts international study group for systemic autoinflammatory diseases (INSAID) decided a consensus classification of likely pathogenic for this variant (Van Gijn_2018). One experimental study reported no substantial increase in spontaneous cell death and TcdA/UCN-01-induced cell death enhancement due to the variant in transfected cells (Honda_2021). ClinVar contains an entry for this variant (Variation ID: 2544). Our laboratory classified this variant as 'pathogenic' in 2016 weighting the expert panel opinion (Shinar_2012) and reports of its presence in patients with clinically or suspected diagnosis of FMF. However, the prevailing consensus for this variant when observed in a clinical diagnostic setting seems to have shifted to an uncertain significance. Based on the evidence outlined above, the variant was re-classified as a VUS-possibly pathogenic. -
Pathogenic, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesMar 25, 2019The MEFV c.800C>T; p.Thr267Ile variant (rs104895081) has been published in the literature in individuals with familial Mediterranean fever (FMF) or juvenile idiopathic arthritis, with or without another pathogenic variant (Bernot 1998, Ceylan 2012, Comak 2013, Dogan 2015, Giaglis 2007, Oztuzcu 2014). This variant is listed in the ClinVar database (Variation ID: 2544) and listed in the general population with an overall allele frequency of 0.015% (42/282848 alleles) in the Genome Aggregation Database. Considering available information, this variant is classified as pathogenic. References: Bernot A et al. Non-founder mutations in the MEFV gene establish this gene as the cause of familial Mediterranean fever (FMF). Hum Mol Genet. 1998 Aug;7(8):1317-25. Ceylan GG et al. Frequency of alterations in the MEFV gene and clinical signs in familial Mediterranean fever in Central Anatolia, Turkey. Genet Mol Res. 2012 May 7;11(2):1185-94. Comak E et al. MEFV gene mutations in Turkish children with juvenile idiopathic arthritis. Eur J Pediatr. 2013 Aug;172(8):1061-7. Dogan H et al. Familial Mediterranean fever gene mutations in north-eastern part of Anatolia with special respect to rare mutations. Gene. 2015 Sep 1;568(2):170-5. Giaglis S et al. MEFV alterations and population genetics analysis in a large cohort of Greek patients with familial Mediterranean fever. Clin Genet. 2007 May;71(5):458-67. Oztuzcu S et al. Screening of common and novel familial mediterranean fever mutations in south-east part of Turkey. Mol Biol Rep. 2014;41(4):2601-7. -
Familial Mediterranean fever, autosomal dominant Uncertain:1Other:1
Uncertain significance, criteria provided, single submitterclinical testingBaylor GeneticsJun 24, 2023- -
not provided, no classification providedphenotyping onlyGenomeConnect - Invitae Patient Insights Network-Variant interpreted as Uncertain significance and reported on 09-24-2018 by Invitae. GenomeConnect-Invitae Patient Insights Network assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. Phenotypic details are available under supporting information. -
Autoinflammatory syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitterclinical testingGenome Diagnostics Laboratory, The Hospital for Sick ChildrenJul 02, 2021- -
MEFV-related disorder Uncertain:1
Uncertain significance, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesNov 22, 2023The MEFV c.800C>T variant is predicted to result in the amino acid substitution p.Thr267Ile. This variant is reported in 0.033% of alleles in individuals of South Asian descent in gnomAD. It been reported in the homozygous state in an individual with familial Mediterranean fever (FMF) (Giaglis et al. 2007. PubMed ID: 17489852) and in the presence of a second MEFV variant; however, phase was not reported (Moradian et al. 2010. PubMed ID: 20485448; Oztuzcu et al. 2014. PubMed ID: 24469716). This variant was also reported in an individual with FMF and two other established pathogenic MEFV variants; however, the phase of this complex allele was not reported (Cornelius and Duno 2011. PubMed ID: 20721559). The c.800C>T (p.Thr267Ile) variant and another MEFV variant were reported in an individual with oligoarthritis; however, phase of the variants was not reported (Comak et al. 2013. PubMed ID: 23588594). This variant has been reported in the heterozygous state in individuals with FMF in which a second MEFV variant was not found or additional information on other variants was not provided (NAJ: 21-31, Bernot et al. 1998. PubMed ID: 9668175; Medlej-Hashim et al. 2005. PubMed ID: 16378925; Ceylan et al. 2012. PubMed ID: 22614345; Oztuzcu et al. 2014. PubMed ID: 24469716; Balta et al. 2020. PubMed ID: 31989427). Of note, FMF symptoms in patients with a single heterozygous MEFV variant could be due to an undetected second variant present in the gene or some patients with a single heterozygous variant could be mildly affected (Moradian et al. 2010. PubMed ID: 20485448). An in vitro functional study of monocytes expressing MEFV variants utilized flow cytometry to evaluate the impact the variants had on cell death showed that the p.Thr267Ile variant did not alter cell death rates and results were similar to that of wild type MEFV (Honda et al. 2021. PubMed ID: 33733382). Previous classifications of this variant determined it was causative (Shinar et al. 2012. PubMed ID: 22661645; Van Gijn et al. 2018. PubMed ID: 29599418; INFEVERS database); however, more recent classifications suggest this variant is of uncertain significance (https://www.ncbi.nlm.nih.gov/clinvar/variation/2544/). PreventionGenetics classified this variant as ‘pathogenic’ in 2015 based on the literature available at the time; however, based on current evidence the classification of this variant has shifted and now the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.23
T
BayesDel_noAF
Benign
-0.27
CADD
Benign
0.054
DANN
Benign
0.94
DEOGEN2
Benign
0.30
T
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.5
FATHMM_MKL
Benign
0.013
N
LIST_S2
Benign
0.34
T
M_CAP
Benign
0.020
T
MetaRNN
Pathogenic
0.83
D
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.55
N
MutationTaster
Benign
3.4e-12
A;A;A;A
PrimateAI
Benign
0.27
T
PROVEAN
Benign
-0.74
N
REVEL
Uncertain
0.32
Sift
Benign
0.15
T
Sift4G
Benign
0.14
T
Polyphen
0.47
P
Vest4
0.65
MVP
0.36
MPC
0.13
ClinPred
0.031
T
GERP RS
-4.3
Varity_R
0.031
gMVP
0.21

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs104895081; hg19: chr16-3304268; API